MétaCan
Menu
Back to cohort
Record W3042459194 · doi:10.3747/co.27.5707

Barriers to Conducting Cancer Trials in CanadA: An Analysis of Key Informant Interviews

2020· article· en· W3042459194 on OpenAlexaffvenueabout
Colene Bentley, Stephen Sundquist, Janet Dancey, Stuart Peacock

Bibliographic record

VenueCurrent Oncology · 2020
Typearticle
Languageen
FieldMedicine
TopicEthics in Clinical Research
Canadian institutionsQueen's UniversityHIV Legal NetworkSimon Fraser UniversityCanadian Breast Cancer NetworkCanadian Cancer SocietyOntario Institute for Cancer ResearchCanadian Centre for Applied Research in Cancer Control
Fundersnot available
KeywordsClinical trialMedicineReimbursementGrounded theoryPublic relationsHealth careFamily medicineMedical educationQualitative researchPolitical sciencePathology

Abstract

fetched live from OpenAlex

Background: In Canada, there is growing evidence that oncology clinical trials units (ctus) and programs face serious financial challenges. Investment in cancer research in Canada has declined almost 20% in the 5 years since its peak in 2011, and the costs of conducting leading-edge trials are rising. Clinical trials units must therefore be strategic about which studies they open. We interviewed Canadian health care professionals responsible for running cancer trials programs to identify the barriers to sustainability that they face. Methods: One-on-one telephone interviews were conducted with clinicians and clinical research professionals at oncology ctus in Canada. We asked for their perspectives about the barriers to conducting trials at their institutions, in their provinces, and nationwide. Interviews were digitally recorded, transcribed, anonymized, and coded in the NVivo software application (version 11: QSR International, Melbourne, Australia). The initial coding structure was informed by the interview script, with new concepts drawn out and coded during analysis, using a constant comparative approach. Results: Between June 2017 and November 2018, 25 interviews were conducted. Key barriers that participants identified were■ insufficient stable funding to support trials infrastructure and retain staff;■ the need to adopt strict cost-recovery policies, leading to fewer academic trials in portfolios; and■ an overreliance on industry to fund clinical research in Canada. Conclusions: Funding uncertainties have led ctus to increasingly rely on industry sponsorship and more stringent feasibility thresholds to remain solvent. Retaining skilled trials staff can create efficiencies in opening and running studies, with spillover effects of more trials being open to patients. More academic studies are needed to curb industry's influence.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Direct model labels (unvalidated)

Per-model category and study-design labels from the labeling rounds. They are machine output, unvalidated, and the disagreement between models ships as data. No study design here is MEDLINE-validated yet.

Model armCategoriesStudy designConfidence
gemmaMetaresearch
Domain: Methods · Genre: Empirical
About the Canadian research system: yes · About a Canadian topic: yes
Qualitativehigh
gptMetaresearch
Domain: Methods · Genre: Empirical
About the Canadian research system: yes · About a Canadian topic: yes
Qualitativelow
models agreeAgreement compares identical category sets and study designs across arms.

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.040
metaresearch head score (Gemma)0.085
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Qualitative · Consensus signal: Qualitative
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.960
Threshold uncertainty score0.756

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0400.085
Meta-epidemiology (narrow)0.0010.002
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0050.010
Science and technology studies0.0230.009
Scholarly communication0.0070.003
Open science0.0040.008
Research integrity0.0030.005
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.903
GPT teacher head0.701
Teacher spread0.202 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Labeled directly by 2 models reading the full record.

Study designQualitative
DomainMethods
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2020
Admission routes3
Has abstractyes

Explore more

Same venueCurrent OncologySame topicEthics in Clinical ResearchCategoryMetaresearchFrench-language works237,207